Fate Therapeutics Inc. buy Mizuho
Start price
20.11.23
/
50%
€2.37
Target price
20.11.24
€7.31
Performance (%)
-14.58%
End price
21.11.24
€2.03
Summary
This prediction ended on 21.11.24 with a price of €2.03. The price of Fate Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.58%. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fate Therapeutics Inc. | -17.926% | -17.926% | 81.350% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by Mizuho for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target lowered by analysts at Mizuho from $12.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten